Rahul N Khurana

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Vascular Endothelial Growth Factor

Radiation Therapy

Age Related Macular Degeneration

Top Venues

Clinical ophthalmology (Auckland, N.Z.)

The British journal of ophthalmology

This page only lists publications with an associated author ORCID identifier.

Publications

David Callanan, Rahul N Khurana, Raj K Maturi, Sunil Patel, Charles C Wykoff, David A Eichenbaum, Arshad M Khanani, Tarek Hassan, Hanh Badger, Shraddha Mehta, Grace Le, Mayssa Attar, Jennifer Seal, Xiao-Yan Li
Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results. Clinical ophthalmology (Auckland, N.Z.) 17 (2023)
David Callanan, Rahul N Khurana, Raj K Maturi, Sunil Patel, Charles C Wykoff, David A Eichenbaum, Arshad M Khanani, Tarek Hassan, Hanh Badger, Shraddha Mehta, Grace Le, Mayssa Attar, Jennifer Seal, Xiao-Yan Li
Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results. Clinical ophthalmology (Auckland, N.Z.) 17 (2023)
Rahul N Khurana, Pauline T Merrill, Steven Yeh, Eric Suhler, Mark R Barakat, Eduardo Uchiyama, Christopher Ryan Henry, Milan Shah, Robert C Wang, Barry Kapik, Thomas A Ciulla
Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA). The British journal of ophthalmology (2021)
Christopher Ryan Henry, Milan Shah, Mark R Barakat, Pouya Dayani, Robert C Wang, Rahul N Khurana, Lana Rifkin, Steven Yeh, Colette Hall, Thomas A Ciulla
Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA). The British journal of ophthalmology (2021)